ABC News’ Phil Lipof speaks with law professor Anya Prince on how 23andMe’s recent layoffs and shuttering of its drug ...

Kennedy is Trump’s pick for health secretary, but he has a history of spreading misinformation about a range of issues.

Revumenib is now an FDA-approved treatment for adult and pediatric patients with relapsed/refractory KMT2A-rearranged acute ...

Eyenovia said on Friday it will discontinue a late-stage study for its experimental drug-device combination to treat near-sightedness and cut about 50% of its workforce.

As optimism for GLP-1 receptor agonists for weight loss has grown, so too has their use in children. Currently, liraglutide ...

Clinical trials are a significant part of the drug development cycle. However, the process has remained unchanged in recent ...

Eli Lilly contends it should be allowed to vet data from 340B hospitals before providing rebates, rather than offer upfront ...

Put up against placebo in the phase 3 EMBARK trial, delandistrogene moxeparvovec (Elevidys) did not significantly improve ...

New analysis from the DETECT-A study supports MCED testing as a complement to current guideline-recommended screening in lung ...

A key challenge for AI-reliant medical devices is the amount of data needed to train their models. In the U.S., such ...

A new CDC report shows at least 16,000 lives were saved over a 12-month period. Experts say the U.S. is experiencing the ...

The FDA's Dr. Peter Marks says he hopes to keep his job under a second Trump term, and urges Robert F. Kennedy Jr. to "keep ...